Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.
Interviews with 23 mephedrone users were completed during a two-month period (May and June 2010) following the legislation that made the drug illegal in the UK. Study participants were aged 19 to 51 years, around half of whom (12) were female. 19 of the 23 people who took part in the study were employed, and most occupations were affiliated with business, trades, the service industry or the public sector.
The research was led by Dr Karen McElrath at Queen's School of Sociology, Social Policy and Social Work.
The key findings from the study were:
21 of the 23 study participants had used mephedrone after the ban.
Only one person was very much opposed to using the substance again.
Approximately half the sample preferred mephedrone to cocaine or ecstasy. Some had experienced negative effects, for example, sleeplessness, difficult comedowns and next-day depression, but these factors generally did not deter them from using the substance again.
None of those who took part in the research felt that 'legal highs' were safe simply because they were legal.
None of the study participants recalled an initial interest in using mephedrone because it had been legal. Rather, its legality before April 2010 meant that it was easier to access and cheaper than many illegal substances.
Prior to the ban, only three interviewees had purchased mephedrone from 'head shops' and four interviewees had purchased mephedrone from online suppliers.
The majority tended to access mephedrone through friends or dealers.
The majority of interviewees had prior experience of taking ecstasy, amphetamine or cocaine.
During their most recent use of mephedrone, all the study participants had also consumed alcohol, although the timing and amount of alcohol varied.
During their most recent use of mephedrone, six of the 23 participants had used another psychoactive substance, other than alcohol.
During their most recent use of mephedrone, most participants had consumed between one-two grams of the drug, although half recalled bingeing on mephedrone, sharing upward of seven-eight grams with two to three other people.
Dr McElrath said: "This is one of the first studies into mephedrone use in Northern Ireland since it was made illegal earlier this year. The findings suggest that the ban did not have a significant impact on those who already used mephedrone, at least during the two-month period that followed the ban. We are keen to develop this research further and to compare our results with a similar study conducted in Waterford prior to the ban on mephedrone in the Republic of Ireland in May 2010."
The study was part of a cross-border research partnership with Marie Clare Van Hout at the Waterford Institute of Technology.
Media inquiries to Anne-Marie Clarke at Queen's Press and PR Unit on +44 (0)28 9097 5320 or +44 (0)7814415451 or firstname.lastname@example.org
Notes to editors:
1. Dr Karen McElrath is available for interview.
2. Mephedrone was made illegal in the UK in April 2010, and in the Republic of Ireland in May 2010.
3. For more information about Marie Clare Van Hout's research in the Republic of Ireland, contact 00353 872375979.
Anne-Marie Clarke | EurekAlert!
New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy